ClearMed
All Pulmonology BriefingsAmerican Journal of Respiratory and Critical Care Medicine
PulmonologyReal-World Cohort3 min read

The Future of AI in Critical Care: An Exploration in Ten Parables

They are intended to help clinicians, institutions, and regulators envision a range of potential scenarios and think broadly about which applications to pursue, which risks to consider, and which rules to establish before AI systems become entrenched.

Published in American Journal of Respiratory and Critical Care MedicineObservational cohort study
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

We close with a set of questions designed to focus that speculation among the interested parties who will shape the future of AI in critical care.

What Changes?

Pulmonology · Real-World Cohort

Current Standard

Within each parable we try to keep visible what current evidence already supports and what remains speculative.

New Finding

Through ten parables, we describe plausible benefits, harms, and trade-offs involving prognosis, monitoring, liability, research, clinical work, data governance, education, and triage.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    Each parable reveals how the outlook for AI in critical care is characterized by uncertainty.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

What This Means for You

Within each parable we try to keep visible what current evidence already supports and what remains speculative. We close with a set of questions designed to focus that speculation among the interested parties who will shape the future of AI in critical care.

The Discovery

We cannot know how artificial intelligence (AI) will ultimately change critical care, only that it is driving substantial change quickly. Through ten parables, we describe plausible benefits, harms, and trade-offs involving prognosis, monitoring, liability, research, clinical work, data governance, education, and triage. They are intended to help clinicians, institutions, and regulators envision a range of potential scenarios and think broadly about which applications to pursue, which risks to consider, and which rules to establish before AI systems become entrenched. Each parable reveals how the outlook for AI in critical care is characterized by uncertainty. This includes uncertainty about what a single prediction means for the patient in front of us, how an application built and tested in one setting performs in another, accountability frameworks, professional practice and learning, patient privacy and autonomy, and more.

How It Works, Simply

This pulmonology research focuses on AI model. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    Each parable reveals how the outlook for AI in critical care is characterized by uncertainty.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

01

Biological Mechanism & Study Design

Study Design & Cohort

Observational cohort study

Observational cohort study · Real-World Cohort

Biological Pathway & Modality

AI model

Intervention: The Future of AI in Critical Care: An Exploration in Ten Parables

02

Experimental Findings & Endpoints

We cannot know how artificial intelligence (AI) will ultimately change critical care, only that it is driving substantial change quickly.

Through ten parables, we describe plausible benefits, harms, and trade-offs involving prognosis, monitoring, liability, research, clinical work, data governance, education, and triage. They are intended to help clinicians, institutions, and regulators envision a range of potential scenarios and think broadly about which applications to pursue, which risks to consider, and which rules to establish before AI systems become entrenched.

Each parable reveals how the outlook for AI in critical care is characterized by uncertainty. This includes uncertainty about what a single prediction means for the patient in front of us, how an application built and tested in one setting performs in another, accountability frameworks, professional practice and learning, patient privacy and autonomy, and more.

03

Clinical Translation & Practice Context

Within each parable we try to keep visible what current evidence already supports and what remains speculative.

We close with a set of questions designed to focus that speculation among the interested parties who will shape the future of AI in critical care.

03

The Bottom Line · Clinical Pearl

“We close with a set of questions designed to focus that speculation among the interested parties who will shape the future of AI in critical care.”

Published in American Journal of Respiratory and Critical Care Medicine · Current Stage: Real-World Cohort

Pulmonology · Real-World Cohort
Study Type
Observational cohort study

Observational cohort study

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Observational cohort study in pulmonology care
Intervention & Mechanism
The Future of AI in Critical Care: An Exploration in Ten Parables

AI model

Key Limitation
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as Observational cohort study along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Indexed Clinical Entities

Original Publication & AMA Citation

The Future of AI in Critical Care: An Exploration in Ten Parables. American Journal of Respiratory and Critical Care Medicine. Published 2026;Oct 29. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42954287/

American Journal of Respiratory and Critical Care Medicine

https://pubmed.ncbi.nlm.nih.gov/42954287/

Read Original Paper

Continue Reading

Related in Pulmonology

View all Pulmonology briefings →
PULMONOLOGY · CLINICAL PRACTICE

Mediastinal Mass With Recurrent Hemorrhagic Pleural Effusion

Empirical antituberculosis therapy also was given, but no definitive diagnosis was established. A 55-year-old man was admitted with a 2-year history of recurrent dyspnea and exertional breathlessness, accompanied by intermittent blood-tinged sputum.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readChest
PULMONOLOGY · CLINICAL PRACTICE

Bilateral Pulmonary Nodules After Lung Transplantation: A Rare Diagnosis

He was also placed on mycophenolic acid, which was soon held because of neutropenia. Antibody-mediated rejection was successfully treated with our institutional multimodal regimen, including a combination of plasmapheresis, carfilzomib, and anti-thymocyte globulin followed by monthly IV immunoglobulin and tocilizumab injections.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readChest
PULMONOLOGY · CLINICAL PRACTICE

A Young Man With Hypereosinophilia and Pseudochylothorax

There was no other significant environmental history. The patient received anti-tubercular therapy along with tapering corticosteroids, showing initial clinical improvement.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readChest